Market Overview:
The global thiazide diuretic market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of hypertension, cardiovascular disorders, and kidney disorders across the globe. Additionally, rising awareness about the benefits of thiazide diuretics is also contributing to the growth of this market. Based on type, hydrochlorothiazide accounted for the largest share of the global thiazide diuretic market in 2017. This can be attributed to its high efficacy and safety profile compared with other types of thiazide diuretics. Based on application, hypertension was the largest segment in 2017 and is expected to continue its dominance duringthe forecast period owingtoits high prevalence worldwide.
Product Definition:
A thiazide diuretic is a type of medication that helps the body get rid of excess water and salt. It does this by making the kidneys produce more urine.
Hydrochlorothiazide:
Hydrochlorothiazide, also known as hydrochlorthiazide or HCTZ, is a medication used for the treatment of hypertension and water retention (edema). It works by decreasing the ability of the kidneys to excrete salt and water. Hydrochlorothiazide has been in use since 1960s. The drug was developed by Ciba Pharmaceutical Company and was first sold under their brand name “Aldactone” in Europe and Japan in 1969.
Chlorothiazide:
Chlorothiazide is a thiazide diuretic. It works by reducing the amount of fluid in the cells and tissues, which results in increased urine production. Chlorothiazide is used to treat heart failure, hypertension, glaucoma eye pressure medication and urinary tract infections among others.
Application Insights:
The hypertension application segment led the global thiazide diuretic market in 2017. Hypertension is a major public health concern as it increases the risk of cardiovascular diseases and stroke. According to WHO, more than 300 million people have hypertension worldwide, out of which about 25% are affected by stage 1-4 hypertension and 75% are affected by stage 5 or higher BP.
Chronic kidney disease (CKD) is expected to be one of the fastest growing applications over the forecast period due to rising awareness regarding lifestyle modifications including diet and exercise along with appropriate medication for maintaining a healthy lifestyle for avoiding further complications related to CKD such as cardiovascular disorders, bone fractures etc. Moreover, increasing cases of diabetic nephropathy will boost demand over the forecast period owing to its high prevalence among diabetes patients coupled with an increase in life expectancy globally will further fuel growth during this period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of hypertension, cardiovascular disorders, and hepatic disorders in this region. Moreover, increasing awareness about these products and their benefits is expected to fuel the regional market growth during the forecast period. Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income levels coupled with growing healthcare spending by governments & private sectors in countries such as China & India. In addition, improving lifestyle habits such as a decrease in alcohol consumption and smoking are anticipated to further boost product demand over this period.
Major players operating across segments include Abbott; Bristol-Myers Squibb Company; FrieslandCampina Holdings Nv; GlaxoSmithKline plc.; Johnson & Johnson Services Inc.
Growth Factors:
- Increasing prevalence of hypertension and other cardiac disorders
- Rising geriatric population susceptible to heart diseases
- Growing awareness about the benefits of thiazide diuretics in preventing heart failures and other cardiac complications
- Technological advancements in the manufacturing of thiazide diuretics that improve their efficacy and safety profile
- Availability of generic versions of branded thiazide diuretics at affordable prices
Scope Of The Report
Report Attributes
Report Details
Report Title
Thiazide Diuretic Market Research Report
By Type
Hydrochlorothiazide, Chlorothiazide, Chlorthalidone, Indapamide, Others
By Application
Hypertension, Cardiovascular Disorders, Hepatic Disorders, Kidney Disorders, Others
By Companies
Sanofi, Pfizer, Merck Sharp and Dohme, Lannett, Novartis, Teva, Centaur Pharmaceuticals, Validus Pharmaceuticals, Boehringer Ingelheim, GlaxoSmithKline (GSK), Sun Pharmaceuticals, Stadmed, Biogen, Micro Labs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Thiazide Diuretic Market Report Segments:
The global Thiazide Diuretic market is segmented on the basis of:
Types
Hydrochlorothiazide, Chlorothiazide, Chlorthalidone, Indapamide, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hypertension, Cardiovascular Disorders, Hepatic Disorders, Kidney Disorders, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Pfizer
- Merck Sharp and Dohme
- Lannett
- Novartis
- Teva
- Centaur Pharmaceuticals
- Validus Pharmaceuticals
- Boehringer Ingelheim
- GlaxoSmithKline (GSK)
- Sun Pharmaceuticals
- Stadmed
- Biogen
- Micro Labs
Highlights of The Thiazide Diuretic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hydrochlorothiazide
- Chlorothiazide
- Chlorthalidone
- Indapamide
- Others
- By Application:
- Hypertension
- Cardiovascular Disorders
- Hepatic Disorders
- Kidney Disorders
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thiazide Diuretic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A thiazide diuretic is a type of medication that helps to reduce the amount of water that is lost from the body through urination. This can help to lower blood pressure and improve blood flow.
Some of the major players in the thiazide diuretic market are Sanofi, Pfizer, Merck Sharp and Dohme, Lannett, Novartis, Teva, Centaur Pharmaceuticals, Validus Pharmaceuticals, Boehringer Ingelheim, GlaxoSmithKline (GSK), Sun Pharmaceuticals, Stadmed, Biogen, Micro Labs.
The thiazide diuretic market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thiazide Diuretic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thiazide Diuretic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thiazide Diuretic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thiazide Diuretic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thiazide Diuretic Market Size & Forecast, 2018-2028
4.5.1 Thiazide Diuretic Market Size and Y-o-Y Growth
4.5.2 Thiazide Diuretic Market Absolute $ Opportunity
Chapter 5 Global Thiazide Diuretic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thiazide Diuretic Market Size Forecast by Type
5.2.1 Hydrochlorothiazide
5.2.2 Chlorothiazide
5.2.3 Chlorthalidone
5.2.4 Indapamide
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thiazide Diuretic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thiazide Diuretic Market Size Forecast by Applications
6.2.1 Hypertension
6.2.2 Cardiovascular Disorders
6.2.3 Hepatic Disorders
6.2.4 Kidney Disorders
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thiazide Diuretic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thiazide Diuretic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thiazide Diuretic Analysis and Forecast
9.1 Introduction
9.2 North America Thiazide Diuretic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thiazide Diuretic Market Size Forecast by Type
9.6.1 Hydrochlorothiazide
9.6.2 Chlorothiazide
9.6.3 Chlorthalidone
9.6.4 Indapamide
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thiazide Diuretic Market Size Forecast by Applications
9.10.1 Hypertension
9.10.2 Cardiovascular Disorders
9.10.3 Hepatic Disorders
9.10.4 Kidney Disorders
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thiazide Diuretic Analysis and Forecast
10.1 Introduction
10.2 Europe Thiazide Diuretic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thiazide Diuretic Market Size Forecast by Type
10.6.1 Hydrochlorothiazide
10.6.2 Chlorothiazide
10.6.3 Chlorthalidone
10.6.4 Indapamide
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thiazide Diuretic Market Size Forecast by Applications
10.10.1 Hypertension
10.10.2 Cardiovascular Disorders
10.10.3 Hepatic Disorders
10.10.4 Kidney Disorders
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thiazide Diuretic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thiazide Diuretic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thiazide Diuretic Market Size Forecast by Type
11.6.1 Hydrochlorothiazide
11.6.2 Chlorothiazide
11.6.3 Chlorthalidone
11.6.4 Indapamide
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thiazide Diuretic Market Size Forecast by Applications
11.10.1 Hypertension
11.10.2 Cardiovascular Disorders
11.10.3 Hepatic Disorders
11.10.4 Kidney Disorders
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thiazide Diuretic Analysis and Forecast
12.1 Introduction
12.2 Latin America Thiazide Diuretic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thiazide Diuretic Market Size Forecast by Type
12.6.1 Hydrochlorothiazide
12.6.2 Chlorothiazide
12.6.3 Chlorthalidone
12.6.4 Indapamide
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thiazide Diuretic Market Size Forecast by Applications
12.10.1 Hypertension
12.10.2 Cardiovascular Disorders
12.10.3 Hepatic Disorders
12.10.4 Kidney Disorders
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thiazide Diuretic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thiazide Diuretic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thiazide Diuretic Market Size Forecast by Type
13.6.1 Hydrochlorothiazide
13.6.2 Chlorothiazide
13.6.3 Chlorthalidone
13.6.4 Indapamide
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thiazide Diuretic Market Size Forecast by Applications
13.10.1 Hypertension
13.10.2 Cardiovascular Disorders
13.10.3 Hepatic Disorders
13.10.4 Kidney Disorders
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thiazide Diuretic Market: Competitive Dashboard
14.2 Global Thiazide Diuretic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Pfizer
14.3.3 Merck Sharp and Dohme
14.3.4 Lannett
14.3.5 Novartis
14.3.6 Teva
14.3.7 Centaur Pharmaceuticals
14.3.8 Validus Pharmaceuticals
14.3.9 Boehringer Ingelheim
14.3.10 GlaxoSmithKline (GSK)
14.3.11 Sun Pharmaceuticals
14.3.12 Stadmed
14.3.13 Biogen
14.3.14 Micro Labs
